Lupin's Dapagliflozin Tablets receive US regulatory approval
Insmed reports Phase 2b study of brensocatib did not meet efficacy endpoints
Gilead to acquire Tubulis to expand ADC oncology capabilities
FDA grants Fast Track status to SIM0505 for platinum‑resistant ovarian cancer
Alloy Therapeutics and Biogen expand partnership with multi-target antisense collaboration
Sanofi reports positive phase 2 results for lunsekimig in asthma and CRSwNP
AstraZeneca reports positive Phase III data for Imfinzi and Imjudo in liver cancer
Mary's Medicinals to participate in CMS trial programme with cannabinoid-based wellness products
Lilly's Foundayo (orforglipron) weight loss pill gains US FDA approval
Thermo Fisher Scientific unveils CHOvantage GS Kit to speed biologics development